Feline Leukemia (FeLV) and Vaccination: A Breeder’s Perspective

Feline Leukemia Virus (FeLV) is a serious viral disease in cats, leading to immune system suppression and heightened susceptibility to infections. As a dedicated breeder, ensuring the well-being of my cats is paramount, which includes a thorough understanding of FeLV, its transmission, and preventive measures such as vaccination.

How FeLV Spreads

FeLV spreads primarily through close contact between cats, including grooming, shared food and water bowls, and bite wounds. The virus can also be transmitted from a mother cat to her kittens during birth or nursing. Cats that roam outdoors or live in multi-cat environments are at an elevated risk of contracting FeLV.

Symptoms of FeLV 

FeLV can be insidious, often presenting no symptoms in its early stages, making it challenging to detect without specific tests. As the disease advances, potential symptoms include:

  • Persistent fever
  • Weight loss
  • Lethargy
  • Swollen lymph nodes
  • Pale gums or jaundice (yellowing of the skin)
  • Breathing difficulties
  • Diarrhea
  • Recurring infections
  • Neurological issues in some cases

These symptoms typically worsen over time, leading to significant health challenges for the affected cat.

The Nature of FeLV

FeLV is caused by a retrovirus that compromises the cat's immune system and blood-forming tissues. This virus can trigger the development of tumors, such as lymphomas and leukemias, as well as other FeLV-related diseases, including anemia and various immune-mediated disorders. The severity and outcome of FeLV infection depend on factors like the cat's age, immune system strength, and overall health.

The virus often starts by replicating in the cat's oral tissues before spreading through the bloodstream. If it reaches the bone marrow, widespread infection may occur, leading to severe illness. 

Outcomes of Feline Leukemia Virus (FeLV) Infection.

Diagram illustrating the potential outcomes of Feline Leukemia Virus (FeLV) infection in cats, detailing the stages from exposure to the virus through various infection pathways, including abortive, focal/atypical, regressive, and progressive infections, with associated percentages and potential clinical consequences such as lymphoma, anemia, and reproductive issues.

This diagram illustrates the potential outcomes following a cat's exposure to the Feline Leukemia Virus (FeLV), detailing the different infection pathways and the presence of antibodies.

FeLV Exposure: The process begins with a cat being exposed to FeLV through shared bowls, grooming, bites, or other close contact with an infected cat.

Week 1:

  • Abortive Infection (~25%): Approximately 25% of cats are able to mount an effective immune response early on, leading to an abortive infection. In this scenario, the cat's immune system clears the virus before it can establish a persistent infection. Antibodies against FeLV are produced and can be detected, but the virus itself is not present in the bloodstream or tissues. These cats will test negative for FeLV in antigen and PCR assays but will have developed antibodies to the virus.
  • Focal/Atypical Infection (<5%): Less than 5% of cats develop a focal or atypical infection, where the virus may be present in specific tissues (like the mammary glands or bladder) but not in the blood or bone marrow. The presence of antibodies can be inconsistent in this type of infection, and the infection may be difficult to detect using standard tests.

Week 3:

  • Regressive Infection (~35%): In about 35% of cases, the cat's immune system suppresses the virus, resulting in a regressive infection. Antibodies are present, and viral replication is minimal or absent. This type of infection may persist for life, with the possibility of reactivation under immunosuppression, such as during pregnancy or due to certain medications.
  • Progressive Infection (~35%): In another 35% of cases, the infection progresses, with the virus spreading and establishing a persistent presence in the cat's body. This leads to a progressive infection characterized by persistent viremia. Despite the presence of antibodies, the immune system fails to control the virus, resulting in severe clinical outcomes, including lymphoma, leukemia, fibrosarcomas, anemia, reproductive issues, and neurological disorders.

Understanding these different outcomes is crucial for guiding prevention and treatment strategies.

Diagnosing FeLV 

Feline Leukemia Virus (FeLV) is diagnosed primarily through blood tests. The most common test used is the ELISA (enzyme-linked immunosorbent assay) test, which detects FeLV antigens in the blood. If a cat tests positive, a follow-up test such as the IFA (immunofluorescence assay) is often recommended to confirm the infection and assess the stage of the disease. Early and accurate diagnosis is crucial for managing FeLV and deciding on appropriate care and preventive measures for affected cats.

Treatment for FeLV 

Currently, there is no cure for FeLV. However, supportive care can manage symptoms and improve the quality of life for infected cats. This care may involve antiviral medications, immune-boosting treatments, and managing secondary infections. With proper care, some FeLV-positive cats can live for several years.

Preventing FeLV 

Preventive measures are essential in protecting cats from FeLV. Vaccination is recommended for cats at higher risk, such as those that go outdoors or live with other cats. Keeping cats indoors and testing any new cats before introducing them into a household can also help prevent the spread of FeLV.

As a breeder, I prioritize the health of my cats by ensuring all cats and kittens in my cattery are tested for FeLV and FIV before being introduced to the breeding program. Kittens are also tested before they leave for their new homes, providing assurance to new owners.

Given the controlled environment in my cattery, where the risk of exposure is minimal, I generally do not recommend the FeLV vaccine for my cats. However, vaccination may be necessary for cats that will have outdoor access or live with FeLV-positive cats.

Whether to vaccinate should be a decision made based on the cat’s specific circumstances and in consultation with a veterinarian. For cats that will be kept indoors and have minimal risk of exposure, the necessity of the FeLV vaccine should be carefully considered, with the veterinarian providing a clear rationale for their recommendation.

While vaccines are vital for disease prevention, they also carry risks, such as the development of injection-site sarcomas. The risks of vaccination should be balanced against the benefits, particularly for indoor cats with minimal exposure to the virus.

Conclusion 

FeLV is a serious concern, and prevention is key. While I do not advocate for the FeLV vaccine for every cat, it is an important option for those at risk. My breeding practices include thorough testing and careful management to minimize the need for FeLV vaccination, ensuring that all kittens are healthy and free from the virus before they go to their new homes.

Regular veterinary care, open communication with breeders, and understanding your cat's specific risks are essential in making the best decisions for their health and well-being.